» Articles » PMID: 38725398

Reward, Relief, and Habit Drinking Profiles in Treatment Seeking Individuals with an AUD

Overview
Journal Alcohol Alcohol
Specialty Psychiatry
Date 2024 May 10
PMID 38725398
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: This study aimed to compare reward, relief, and habit treatment-seeking individuals on recent drinking, alcohol use disorder (AUD) phenomenology, and mood. The second aim of the study was to evaluate the predictive validity of reward, relief, and habit profiles.

Method: Treatment-seeking individuals with an AUD (n = 169) were recruited to participate in a medication trial for AUD (NCT03594435). Reward, relief, and habit drinking groups were assessed using the UCLA Reward Relief Habit Drinking Scale. Group differences at baseline were evaluated using univariate analyses of variance. A subset of participants were enrolled in a 12-week, double-blind, placebo-controlled medication trial (n = 102), and provided longitudinal drinking and phenomenology data. The predictive validity of group membership was assessed using linear regression analyses.

Results: At baseline, individuals who drink primarily for relief had higher craving and negative mood than those who drink for reward and habit. Prospectively, membership in the relief drinking group predicted greater alcohol use, greater heavy drinking, and fewer days abstinent compared to those in the reward drinking group. Membership in the relief drinking group also predicted greater alcohol craving, more alcohol-related consequences, and more anxiety symptoms over 12 weeks compared to those in the reward drinking group.

Conclusions: This study provides support for reward and relief drinking motive profiles in treatment-seeking individuals with an AUD. Membership in the relief drinking motive group was predictive of poorer drinking outcomes and more negative symptomology over 12 weeks, indicating that individuals who drink for relief may be a particularly vulnerable sub-population of individuals with AUD.

References
1.
Mann K, Roos C, Hoffmann S, Nakovics H, Lemenager T, Heinz A . Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes. Neuropsychopharmacology. 2017; 43(4):891-899. PMC: 5809801. DOI: 10.1038/npp.2017.282. View

2.
Witkiewitz K, Roos C, Mann K, Kranzler H . Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response. Alcohol Clin Exp Res. 2019; 43(11):2395-2405. PMC: 6824945. DOI: 10.1111/acer.14183. View

3.
Gillan C, Robbins T, Sahakian B, van den Heuvel O, van Wingen G . The role of habit in compulsivity. Eur Neuropsychopharmacol. 2016; 26(5):828-40. PMC: 4894125. DOI: 10.1016/j.euroneuro.2015.12.033. View

4.
Martinotti G, Lupi M, Sarchione F, Santacroce R, Salone A, de Berardis D . The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview. Curr Pharm Des. 2013; 19(35):6367-74. DOI: 10.2174/13816128113199990425. View

5.
Mann K, Kiefer F, Smolka M, Gann H, Wellek S, Heinz A . Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. Alcohol Clin Exp Res. 2009; 33(4):674-83. DOI: 10.1111/j.1530-0277.2008.00884.x. View